# Effect of Somatropin on Left Ventricular Mass in Growth Hormone Deficient Adult Patients

> **NCT01562834** · PHASE4 · COMPLETED · sponsor: **Novo Nordisk A/S** · enrollment: 22 (actual)

## Conditions studied

- Growth Hormone Disorder
- Adult Growth Hormone Deficiency

## Interventions

- **DRUG:** somatropin
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT01562834
- **Lead sponsor:** Novo Nordisk A/S
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1998-10-21
- **Primary completion:** 2002-12-01
- **Final completion:** 2002-12-01
- **Target enrollment:** 22 (ACTUAL)
- **Last updated:** 2024-02-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01562834

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01562834, "Effect of Somatropin on Left Ventricular Mass in Growth Hormone Deficient Adult Patients". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01562834. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*